June 30, 2011 โ€” Micell Technologies Inc. announced that it has completed its review of the scheduled four-month follow-up on the first 10 patients from the DESSOLVE I first-in-human trial of the MiStent drug-eluting coronary stent system ("MiStent DES"), an ultra-thin drug-eluting stent (DES) distinguished by a rapid-absorbing drug/polymer coating formulation. Based on results observed in the DESSOLVE I trial, Micell has reduced the sample size in its DESSOLVE II CE Mark study from 270 to 171 planned subjects.

June 30, 2011 โ€” The MemorialCare Heart and Vascular Institute (MHVI) at Long Beach Memorial has acquired the C7-XR OCT intravascular imaging system from St. Jude Medical. It is an imaging technology platform that aids physicians in the diagnosis and treatment of cardiovascular disease. Using optical coherence tomography (OCT), the system utilizes near-infrared light to create images that go beyond older coronary imaging technologies - such as fluoroscopy and intravascular ultrasound (IVUS) - offering cardiologists an assessment method with enhanced clarity for their patients with coronary artery disease.

June 30, 2011 โ€” Genzyme, a Sanofi company, and Isis Pharmaceuticals Inc. announced today that two additional analyses from phase 3 studies of mipomersen were presented at the 79th European Atherosclerosis Society (EAS) congress.

June 30, 2011 โ€” During the first quarter of 2011, Biosound Esaote completed a name transition to become Esaote North America. The purpose of this transition was to emphasize the relationship with its parent company, the Esaote Group.

June 30, 2011 โ€” Results of a clinical research study at Sharp Memorial Hospital indicate that patients 70 years of age or older have good functional recovery, survival and quality of life at two years when undergoing left ventricular assist device (LVAD) therapy for heart failure. The study was released in the June 21 edition of the Journal of the American College of Cardiology.

June 29, 2011 โ€” Vital Images, a Toshiba Medical Systems company, released Vitrea Enterprise Suite (VES), Version 6.1. Enhancements in Version 6.1 build on the Vitrea Enterprise Suite and improve clinical workflows through advancements such as expanded integration capabilities.

June 29, 2011 โ€” A new study utilizing data from the Intersocietal Commission for the Accreditation of Nuclear Medicine Laboratories (ICANL) suggests that while noncompliance with reporting standards is found in the majority of nuclear cardiology laboratories throughout the U.S., those facilities participating in the ICANL accreditation process demonstrate an increase in compliance over time.

Subscribe to
ยฉ Copyright Wainscot Media. All Rights Reserved.
Subscribe Now